Table 3 Comparison of characteristics of patients that achieved good outcomes in patients which DWF occurred during procedure.

From: Predictors and prognoses of Willisian collateral failure during mechanical thrombectomy

 

Good outcome (N = 12)

Poor outcome (N = 26)

p value

Sex, male

5 (41.7%)

16 (61.5%)

0.252

Age, years

66 ± 9

69 ± 13

0.448

Diabetes mellitus

1 (8.3%)

12 (46.2%)

0.022

Hypertension

7 (58.3%)

14 (53.8%)

0.796

Atrial fibrillation

3 (25.0%)

17 (65.4%)

0.020

Initial NIHSS

16.5 [14.25–21.75]

19.0 [14.0–22.25]

0.839

ASPECTS

6.0 [4.5–7.5]

7.0 [3.0–8.0]

0.793

Primary occlusion ___location

  

0.722

Simple ICA T

7 (58.3%)

16 (61.5%)

 

IIO

1 (8.3%)

4 (15.4%)

 

M1O

4 (33.3%)

6 (23.1%)

 

Tandem occlusion

3 (25.0%)

1 (3.8%)

0.048

Intravenous tPA

7 (58.3%)

12 (46.2%)

0.485

Onset-to-puncture, min

291 ± 121

373 ± 254

0.188

Procedure time, min

53 ± 27

113 ± 55

< 0.001

Primary intracranial modality

  

0.342

Stent retrieval

4 (33.3%)

5 (19.2%)

 

Direct aspiration

8 (66.7%)

21 (80.8%)

 

Balloon guide catheter used

9 (75.0%)

15 (57.7%)

0.304

DWF type

  

0.136

MCA + ACA

11 (91.7%)

26 (100.0%)

 

MCA + PCA

1 (8.3%)

0 (0.0%)

 

Reperfusion outcomes

  

0.145

mTICI 0

0 (0.0%)

1 (3.8%)

 

mTICI 1

1 (8.3%)

1 (3.8%)

 

mTICI 2A

1 (8.3%)

11 (42.3%)

 

mTICI 2B

9 (75.0%)

13 (50.0%)

 

mTICI 3

1 (8.3%)

0 (0.0%)

 

Successful reperfusion

10 (83.3%)

13 (50.0%)

0.051

Reperfusion of newly embolized territory

11 (91.7%)

8 (30.8%)

< 0.001

Baseline DWI (ml, n = 484)

11 [8–53]

12 [4–46]

0.678

Follow-up DWI (ml, n = 427)

26 [9–95]

77 [147–184]

0.006

PH2 or SAH 3–4

0 (0.0%)

4 (15.4%)

0.151

  1. The data are presented as the mean ± standard deviation, number (%), or median [interquartile range], as appropriate.
  2. ASPECTS, Alberta Stroke Program Early CT scores; DWF, dynamic Willisian collateral failure; DWI, diffusion weighted images; IIO, isolated intracranial internal carotid artery occlusion; IQR, interquartile range; M1O, middle cerebral artery M1 occlusion; mTICI, modified thrombolysis In Cerebral Ischemia; NIHSS, National Institute of Health Stroke Scale; PH2, parenchymal hematoma type 2; SAH 3–4, subarachnoid hemorrhage Fisher grade 3–4tPA, tissue plasminogen activator; WCS, Willisian collateral sparing.